News

Federal Court of Justice invalidates SPC for Gilead blockbuster drug Truvada

In Germany, the Federal Court of Justice invalidates Gilead’s Truvada SPC as most other Courts in Europe considering the CJEU’s Teva ruling C-121/17—a step towards harmonisation of EU law on SPCs.

26/09/2020 | Dr. Günter Isenbruck

Congratulations to our Partners Ulrike Herr and Fritz Lahrtz!

Read more on JUVE Patent.

Kontakt

Rufen Sie uns an oder schreiben Sie uns.
Wir beraten Sie gerne.

Telefon

+49 621 42 271-0 (Mannheim)

+49 211 157756-0 (Düsseldorf)

E-Mail

info-man@ib-patent.de